AAAAAA

   
Results: 1-11 |
Results: 11

Authors: Stevens, H de Klerk, JMH Mertens, IJR van Rijk, PP Hene, RJ
Citation: H. Stevens et al., Quantitative baseline renography 48 hours after renal transplantation predicts long-term graft survival, EUR J NUCL, 28(11), 2001, pp. 1677-1681

Authors: Stokkel, MPM de Klerk, JMH Hordijk, GJ
Citation: Mpm. Stokkel et al., Fluorodeoxyglucose positron emission tomography, a new technique for increasing the detection rate of coincident thyroid cancer in head and neck oncology, EUR ARCH OT, 257(10), 2000, pp. 552-554

Authors: Verhaar-Langereis, MJ Bongers, V de Klerk, JMH van Dijk, A Blijham, GH Zonnenberg, BA
Citation: Mj. Verhaar-langereis et al., Interferon-alpha induced changes in CEA expression in patients with CEA-producing tumours, EUR J NUCL, 27(2), 2000, pp. 209-213

Authors: Verhaar-Langereis, MJ Zonnenberg, BA de Klerk, JMH Blijham, GH
Citation: Mj. Verhaar-langereis et al., Radioimmunodiagnosis and therapy, CANC TR REV, 26(1), 2000, pp. 3-10

Authors: van de Ven, PJG de Klerk, JMH Mertens, IJR Koomans, HA Beutler, JJ
Citation: Pjg. Van De Ven et al., Aspirin renography and captopril renography in the diagnosis of renal artery stenosis, J NUCL MED, 41(8), 2000, pp. 1337-1342

Authors: de Klerk, JMH
Citation: Jmh. De Klerk, I-131 therapy: Inpatient or outpatient?, J NUCL MED, 41(11), 2000, pp. 1876-1878

Authors: de Klerk, JMH de Keizer, B Zelissen, PMJ Lips, CMJ Koppeschaar, HPF
Citation: Jmh. De Klerk et al., Fixed dosage of I-131 for remnant ablation in patients with differentiatedthyroid carcinoma without pre-ablative diagnostic I-131 scintigraphy, NUCL MED C, 21(6), 2000, pp. 529-532

Authors: Mertens, IJR de Klerk, JMH Zelissen, PMJ Thijssen, JHH Sie-Go, DMDS Han, SH van Rijk, PP
Citation: Ijr. Mertens et al., Undetectable serum thyroglobulin in a patient with metastatic follicular thyroid cancer, CLIN NUCL M, 24(5), 1999, pp. 346-349

Authors: Han, SH Zonnenberg, BA de Klerk, JMH Quirijnen, JMSP Schip, ADVH van Dijk, A Blijham, GH van Rijk, PP
Citation: Sh. Han et al., Re-186-etidronate in breast cancer patients with metastatic bone pain, J NUCL MED, 40(4), 1999, pp. 639-642

Authors: Stokking, R van Isselt, JW van Rijk, PP de Klerk, JMH Huiskes, AWLC Mertens, IJR Buskens, E Viergever, MA
Citation: R. Stokking et al., Integrated visualization of functional and anatomic brain data: A validation study, J NUCL MED, 40(2), 1999, pp. 311-316

Authors: de Klerk, JMH Zonnenberg, BA Schip, ADV Van Dijk, A Huiskes, AWLC Van Rijk, PP
Citation: Jmh. De Klerk et al., Can bone marrow scintigraphy predict platelet toxicity after treatment with Re-186-HEDP?, NUCL MED C, 20(9), 1999, pp. 833-836
Risultati: 1-11 |